Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by Chopper1BigDogon Jan 19, 2021 9:28am
97 Views
Post# 32325090

Antibiotic Resistance - LEX has the Tec to help:

Antibiotic Resistance - LEX has the Tec to help:This will be the next big problem and LEX has the Tec to help:
Oxford University is opening a new research institute dedicated to tackling resistance to antibiotics.
The university says this is one of the the biggest rising threats to global health, already causing 1.5 million deaths per year worldwide.
The institute will be funded by £100m donated by the Ineos chemical company.
Vice chancellor Louise Richardson said the Covid pandemic had shown the "high cost of ignoring something that is likely to head our way".
'Growing menace'
There will be 50 researchers working in the new Ineos Oxford Institute for Antimicrobial Resistance, addressing the "over-use and mis-use" of antibiotics, which the university warned could cause 10 million excess deaths per year by 2050.
How antibiotics resistance 'could take us back to the dark ages'
Global threat of resistance to antibiotics
Antibiotic use falling but resistance rising
Panorama: The race for a vaccine
Routine operations and "taken-for-granted treatments" would become much riskier without effective antibiotics, said the university.
"The growing menace of bacterial resistance to antibiotics is one of the most under-reported issues of our time," says David Sweetnam, a surgeon advising the new institute.
<< Previous
Bullboard Posts
Next >>